Pubblicazioni

Robust Performance of the Novel Research-Use-Only Idylla GeneFusion Assay Using a Diverse Set of Pathological Samples with a Proposed 1-Day Workflow for Advanced NSCLC Evaluation

2022 - CANCERS

Leone, Alvaro; Muscarella, Lucia Anna; Graziano, Paolo; Tornese, Andrea; Grillo, Lucia Rosalba; Di Lorenzo, Angela; Bronzini, Monica; Scarpino, Stefania; Sparaneo, Angelo; Rossi, Giulio

The European Medicines Agency review of entrectinib for the treatment of adult or paediatric patients with solid tumours who have a neurotrophic tyrosine receptor kinase gene fusions and adult patients with non-small-cell lung cancer harbouring ROS1 rearrangements

2021 - ESMO OPEN

Delgado, J.; Pean, E.; Melchiorri, D.; Migali, C.; Josephson, F.; Enzmann, H.; Pignatti, F.

Expanding the molecular characterization of thoracic inflammatory myofibroblastic tumors beyond ALK gene rearrangements

2019 - JOURNAL OF THORACIC ONCOLOGY

Chang, Jason C; Zhang, Lei; Drilon, Alexander E; Chi, Ping; Alaggio, Rita; Borsu, Laetitia; Benayed, Ryma; Travis, William D; Ladanyi, Marc; Antonescu, Cristina R

Crizotinib plus radiotherapy in brain oligoprogressive NSCLC ROS1 rearranged and PD-L1 strong

2017 - JOURNAL OF THORACIC DISEASE

Occhipinti, M.; Falcone, R.; Onesti, C. E.; Botticelli, A.; Mazzuca, F.; Marchetti, P.; Lauro, S.

High prevalence of ALK+/ROS1+ cases in pulmonary adenocarcinoma of adoloscents and young adults

2016 - LUNG CANCER

Scarpino, Stefania; RAMPIONI VINCIGUERRA, GIAN LUCA; DI NAPOLI, Arianna; Fochetti, Flavio; Uccini, Stefania; Iacono, Daniela; Marchetti, Paolo; Ruco, Luigi

Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement

2015 - THE AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Antonescu, Cr; Suurmeijer, Aj; Zhang, L; Sung, Ys; Jungbluth, Aa; Travis, Wd; Al Ahmadie, H; Fletcher, Cd; Alaggio, Rita